XML 48 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation Recognized

The following table summarizes stock-based compensation expense by financial statement line item in the Company’s condensed consolidated statements of operations for the three and nine months ended December 31, 2020 and 2019:

 

 

 

For the Three Months Ended December 31,

 

 

For the Nine Months Ended December 31,

 

 

 

 

2020

 

 

 

2019

 

 

 

2020

 

 

 

2019

 

 

 

(in $000's)

 

Cost of revenue

 

$

1,061

 

 

$

809

 

 

$

2,689

 

 

$

2,531

 

Research and development

 

 

1,922

 

 

 

1,586

 

 

 

5,069

 

 

 

5,292

 

Selling, general and administrative

 

 

9,873

 

 

 

8,179

 

 

 

25,961

 

 

 

29,196

 

 

 

$

12,856

 

 

$

10,574

 

 

$

33,719

 

 

$

37,019

 

Summary of Stock Option Activity

The following table summarizes the stock option activity for the nine months ended December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Options

 

 

Exercise

 

 

Contractual

 

 

Value

 

 

 

(in thousands)

 

 

Price

 

 

Term (years)

 

 

(in thousands)

 

Outstanding at beginning of period

 

 

869

 

 

$

112.03

 

 

 

5.30

 

 

 

 

 

Granted

 

 

68

 

 

 

222.94

 

 

 

 

 

 

 

 

 

Exercised

 

 

(185

)

 

 

38.16

 

 

 

 

 

 

 

 

 

Cancelled and expired

 

 

(10

)

 

 

225.43

 

 

 

 

 

 

 

 

 

Outstanding at end of period

 

 

741

 

 

$

139.08

 

 

 

5.61

 

 

$

141,158

 

Exercisable at end of period

 

 

566

 

 

$

102.90

 

 

 

4.68

 

 

$

127,947

 

Options vested and expected to vest at end of period

 

 

741

 

 

$

139.08

 

 

 

5.61

 

 

$

141,115

 

Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted

 

 

 

For the Three Months Ended December 31,

 

 

For the Nine Months Ended December 31,

 

 

 

 

2020

 

 

 

2019

 

 

 

2020

 

 

 

2019

 

Weighted average grant-date fair value

 

$

94.64

 

 

$

74.61

 

 

$

76.79

 

 

$

93.68

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Valuation assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Risk-free interest rate

 

 

0.39

%

 

 

1.68

%

 

 

0.31

%

 

 

1.99

%

Expected option life (years)

 

 

4.17

 

 

 

4.10

 

 

 

4.22

 

 

 

4.14

 

Expected volatility

 

 

43.70

%

 

 

42.36

%

 

 

42.85

%

 

 

42.34

%

Restricted Stock Units  
Summary of Restricted Stock Units Activity

 

The following table summarizes activity of restricted stock units for the nine months ended December 31, 2020:

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

 

(in thousands)

 

 

(per share)

 

Restricted stock units at beginning of period

 

 

320

 

 

$

263.92

 

Granted

 

 

227

 

 

 

253.93

 

Vested

 

 

(138

)

 

 

226.94

 

Forfeited

 

 

(105

)

 

 

266.67

 

Restricted stock units at end of period

 

 

304

 

 

$

272.29

 

Summary of Assumptions Used To Value Awards And Estimated Grant-Date Fair Value

The table below sets forth the assumptions used to value the awards and the estimated grant-date fair value:

 

 

 

 

 

 

Risk-free interest rate

 

 

0.2%

 

Expected volatility

 

 

35.5%

 

Dividend yield

 

 

 

Remaining performance period (years)

 

1.9 - 2.9

 

Estimated fair value per share

 

$347.05 - $349.28

 

Target performance (number of shares)

 

 

30,881